It seems that sclerostin are closely associated with TG, BW and BW-related parameters in NAFLD subjects, while are closely correlated with insulin, HOMA-IR and HDL-C in controls (Table 2). The gene discussed is SOST; the disease is metabolic dysfunction-associated steatotic liver disease.